206 related articles for article (PubMed ID: 33459705)
1. AD Resemblance Atrophy Index as a Diagnostic Biomarker for Alzheimer's Disease: A Retrospective Clinical and Biological Validation.
Mai Y; Yu Q; Zhu F; Luo Y; Liao W; Zhao L; Xu C; Fang W; Ruan Y; Cao Z; Lei M; Au L; Mok VCT; Shi L; Liu J
J Alzheimers Dis; 2021; 79(3):1023-1032. PubMed ID: 33459705
[TBL] [Abstract][Full Text] [Related]
2. An MRI-based strategy for differentiation of frontotemporal dementia and Alzheimer's disease.
Yu Q; Mai Y; Ruan Y; Luo Y; Zhao L; Fang W; Cao Z; Li Y; Liao W; Xiao S; Mok VCT; Shi L; Liu J; ;
Alzheimers Res Ther; 2021 Jan; 13(1):23. PubMed ID: 33436059
[TBL] [Abstract][Full Text] [Related]
3. MRI-based Alzheimer's disease-resemblance atrophy index in the detection of preclinical and prodromal Alzheimer's disease.
Liu W; Au LWC; Abrigo J; Luo Y; Wong A; Lam BYK; Fan X; Kwan PWL; Ma HW; Ng AYT; Chen S; Leung EYL; Ho CL; Wong SHM; Chu WC; Ko H; Lau AYL; Shi L; Mok VCT;
Aging (Albany NY); 2021 May; 13(10):13496-13514. PubMed ID: 34091443
[TBL] [Abstract][Full Text] [Related]
4. Automated brain volumetric measures with AccuBrain: version comparison in accuracy, reproducibility and application for diagnosis.
Zhao L; Luo Y; Mok V; Shi L
BMC Med Imaging; 2022 Jul; 22(1):117. PubMed ID: 35787256
[TBL] [Abstract][Full Text] [Related]
5. Risk estimation before progression to mild cognitive impairment and Alzheimer's disease: an AD resemblance atrophy index.
Zhao L; Luo Y; Lew D; Liu W; Au L; Mok V; Shi L;
Aging (Albany NY); 2019 Aug; 11(16):6217-6236. PubMed ID: 31467257
[TBL] [Abstract][Full Text] [Related]
6. Machine Learning-Derived MRI-Based Neurodegeneration Biomarker for Alzheimer's Disease: A Multi-Database Validation Study.
Fan X; Cai Y; Zhao L; Liu W; Luo Y; Au LWC; Shi L; Mok VCT
J Alzheimers Dis; 2024; 97(2):883-893. PubMed ID: 38189749
[TBL] [Abstract][Full Text] [Related]
7. Brain MRI Biomarkers to Predict Cognitive Decline in Older People with Alzheimer's Disease.
Zhu LY; Shi L; Luo Y; Leung J; Kwok T
J Alzheimers Dis; 2022; 88(2):763-769. PubMed ID: 35723095
[TBL] [Abstract][Full Text] [Related]
8. Validation of the Alzheimer's disease-resemblance atrophy index in classifying and predicting progression in Alzheimer's disease.
He Q; Shi L; Luo Y; Wan C; Malone IB; Mok VCT; Cole JH; Anatürk M
Front Aging Neurosci; 2022; 14():932125. PubMed ID: 36062150
[TBL] [Abstract][Full Text] [Related]
9. Critical Comparison of Different Biomarkers for Alzheimer's Disease in a Clinical Setting.
Weise D; Tiepolt S; Awissus C; Hoffmann KT; Lobsien D; Kaiser T; Barthel H; Sabri O; Gertz HJ
J Alzheimers Dis; 2015; 48(2):425-32. PubMed ID: 26402006
[TBL] [Abstract][Full Text] [Related]
10. Cognitive and Brain Profiles Associated with Current Neuroimaging Biomarkers of Preclinical Alzheimer's Disease.
Besson FL; La Joie R; Doeuvre L; Gaubert M; Mézenge F; Egret S; Landeau B; Barré L; Abbas A; Ibazizene M; de La Sayette V; Desgranges B; Eustache F; Chételat G
J Neurosci; 2015 Jul; 35(29):10402-11. PubMed ID: 26203136
[TBL] [Abstract][Full Text] [Related]
11. Standardization of hippocampus volumetry using automated brain structure volumetry tool for an initial Alzheimer's disease imaging biomarker.
Abrigo J; Shi L; Luo Y; Chen Q; Chu WCW; Mok VCT;
Acta Radiol; 2019 Jun; 60(6):769-776. PubMed ID: 30185071
[TBL] [Abstract][Full Text] [Related]
12. Longitudinal structural cerebral changes related to core CSF biomarkers in preclinical Alzheimer's disease: A study of two independent datasets.
Falcon C; Tucholka A; Monté-Rubio GC; Cacciaglia R; Operto G; Rami L; Gispert JD; Molinuevo JL;
Neuroimage Clin; 2018; 19():190-201. PubMed ID: 30023169
[TBL] [Abstract][Full Text] [Related]
13. Comparison of imaging biomarkers for Alzheimer's disease: amyloid imaging with [18F]florbetapir positron emission tomography and magnetic resonance imaging voxel-based analysis for entorhinal cortex atrophy.
Tateno A; Sakayori T; Kawashima Y; Higuchi M; Suhara T; Mizumura S; Mintun MA; Skovronsky DM; Honjo K; Ishihara K; Kumita S; Suzuki H; Okubo Y
Int J Geriatr Psychiatry; 2015 May; 30(5):505-13. PubMed ID: 25043833
[TBL] [Abstract][Full Text] [Related]
14. Alzheimer resemblance atrophy index, BrainAGE, and normal pressure hydrocephalus score in the prediction of subtle cognitive decline: added value compared to existing MR imaging markers.
Giannakopoulos P; Montandon ML; Herrmann FR; Hedderich D; Gaser C; Kellner E; Rodriguez C; Haller S
Eur Radiol; 2022 Nov; 32(11):7833-7842. PubMed ID: 35486172
[TBL] [Abstract][Full Text] [Related]
15. Imaging Biomarkers of Neurodegeneration in Alzheimer's Disease: Distinct Contributions of Cortical MRI Atrophy and FDG-PET Hypometabolism.
Benvenutto A; Giusiano B; Koric L; Gueriot C; Didic M; Felician O; Guye M; Guedj E; Ceccaldi M
J Alzheimers Dis; 2018; 65(4):1147-1157. PubMed ID: 30124446
[TBL] [Abstract][Full Text] [Related]
16. Comparison of Two Analytical Platforms in Cerebrospinal Fluid Biomarkers for the Classification of Alzheimer's Disease Spectrum with Amyloid PET Imaging.
Lim HJ; Park JE; Kim BC; Choi SM; Song MK; Cho SH; Seo HJ; Kim J; Song HC; Choi KY; Lee JJ; Kim HW; Ha JM; Song WK; Park SG; Lee JS; Lee KH
J Alzheimers Dis; 2020; 75(3):949-958. PubMed ID: 32390627
[TBL] [Abstract][Full Text] [Related]
17. Evaluating the association between brain atrophy, hypometabolism, and cognitive decline in Alzheimer's disease: a PET/MRI study.
Chen Y; Wang J; Cui C; Su Y; Jing D; Wu L; Liang P; Liang Z
Aging (Albany NY); 2021 Feb; 13(5):7228-7246. PubMed ID: 33640881
[TBL] [Abstract][Full Text] [Related]
18. A multi-model deep convolutional neural network for automatic hippocampus segmentation and classification in Alzheimer's disease.
Liu M; Li F; Yan H; Wang K; Ma Y; ; Shen L; Xu M
Neuroimage; 2020 Mar; 208():116459. PubMed ID: 31837471
[TBL] [Abstract][Full Text] [Related]
19. Accuracy of Biomarker Testing for Neuropathologically Defined Alzheimer Disease in Older Adults With Dementia.
Fink HA; Linskens EJ; Silverman PC; McCarten JR; Hemmy LS; Ouellette JM; Greer NL; Wilt TJ; Butler M
Ann Intern Med; 2020 May; 172(10):669-677. PubMed ID: 32340038
[TBL] [Abstract][Full Text] [Related]
20. Association of Altered Liver Enzymes With Alzheimer Disease Diagnosis, Cognition, Neuroimaging Measures, and Cerebrospinal Fluid Biomarkers.
Nho K; Kueider-Paisley A; Ahmad S; MahmoudianDehkordi S; Arnold M; Risacher SL; Louie G; Blach C; Baillie R; Han X; Kastenmüller G; Trojanowski JQ; Shaw LM; Weiner MW; Doraiswamy PM; van Duijn C; Saykin AJ; Kaddurah-Daouk R;
JAMA Netw Open; 2019 Jul; 2(7):e197978. PubMed ID: 31365104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
